ENSC — Ensysce Biosciences Share News
0.000.00%
Last trade - 00:00- $9.15m
- $8.35m
- $5.07m
Brief: Ensysce Biosciences Announces First Patients Enrolled In Phase 1 Study Of Pf614-Mpar
U.S. STOCKS ON THE MOVE-Torrid, Uber, Reata Pharma, Bakkt, Lyft
U.S. STOCKS ON THE MOVE-Pfizer, PagerDuty, Stitch Fix, Ford
Brief: Ensysce Biosciences Announces Clinical Trial Progress Of Its New Class Of Opioids
Brief: Ensysce Biosciences Reports Q3 Net Loss Of $17.2 Mln Vs. Net Income Of $1.6 Mln In Q3 2020
Brief: Ensysce Biosciences Announces Completion Of $15 Million Convertible Note Financing
Brief: Ensysce Biosciences Announces $15 Mln Convertible Note Financing
NASDAQ RESUMED AT 02:11 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:01 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:43 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:36 AM
Brief: Ensysce Biosciences Reports Second Quarter 2021 Financial Results And Recent Corporate Updates
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:46 PM
NASDAQ RESUMED AT 09:39 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM
Brief: Ensysce Biosciences Receives Notice Of Award For Year Three Of Multi-Year Nida Grant For Development Of Its Next Generation Opioid Products
NASDAQ RESUMED AT 03:15 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:04 PM
NASDAQ RESUMED AT 02:56 PM